P2Y13 Polymorphism and Myocardial Infarction
Author Information
Author(s): Amisten Stefan, Braun Oscar Ö., Johansson Lovisa, Ridderstråle Martin, Melander Olle, Erlinge David
Primary Institution: Lund University Hospital
Hypothesis
The P2Y13 Met-158-Thr polymorphism is associated with acute myocardial infarction (AMI) or classical risk factors for AMI.
Conclusion
The P2Y13 Met-158-Thr polymorphism is not associated with AMI or classical cardiovascular risk factors.
Supporting Evidence
- The P2Y13 Met-158-Thr polymorphism was found to be in linkage disequilibrium with the P2Y12 H2 haplotype.
- Genotyping revealed no association of the P2Y13 Thr-158 allele with AMI.
- No differences were seen in genotype frequencies among AMI case-control subpopulations.
- The study included over 10,000 individuals across three populations.
Takeaway
This study looked at a gene variant to see if it was linked to heart attacks, but it found no connection.
Methodology
Genotyping of the P2Y13 Met-158-Thr polymorphism was performed in three study populations totaling over 10,000 individuals.
Limitations
The study did not adjust for multiple testing, which could affect the results.
Participant Demographics
The study included a diverse population from Malmö, Sweden, with both men and women aged 23-50.
Statistical Information
P-Value
0.63
Confidence Interval
0.82–1.12
Statistical Significance
p=0.63
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website